Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Further Optimization of the mGlu1 PAM VU6024578/BI02982816: Discovery and Characterization of VU6033685.
Journal: ACS chemical neuroscience
Published: February 05, 2025
Targeting the Actions of Muscarinic Receptors on Dopamine Systems: New Strategies for Treating Neuropsychiatric Disorders.
Journal: Annual review of pharmacology and toxicology
Published: August 08, 2023
Activation of Metabotropic Glutamate Receptor 3 Modulates Thalamo-accumbal Transmission and Rescues Schizophrenia-Like Physiological and Behavioral Deficits.
Journal: Biological psychiatry
Published: August 07, 2023
Bridging the gap in neuropsychiatric translational research.
Journal: Trends in pharmacological sciences
Published: November 11, 2022
Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits.
Journal: Frontiers in neuroscience
Published: April 21, 2022
Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder.
Journal: Journal of medicinal chemistry
Published: April 13, 2022
mGlu1-mediated restoration of prefrontal cortex inhibitory signaling reverses social and cognitive deficits in an NMDA hypofunction model in mice.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: February 03, 2022
Muscarinic receptors: from clinic to bench to clinic.
Journal: Trends in pharmacological sciences
Published: December 27, 2021
Targeting muscarinic receptors to treat schizophrenia.
Journal: Behavioural brain research
Published: November 16, 2020
Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy.
Journal: ACS pharmacology & translational science
Published: October 02, 2020
Examining the role of muscarinic M5 receptors in VTA cholinergic modulation of depressive-like and anxiety-related behaviors in rats.
Journal: Neuropharmacology
Published: December 17, 2019
Highly Speciated Measurements of Terpenoids Emitted from Laboratory and Mixed-Conifer Forest Prescribed Fires.
Journal: Environmental science & technology
Published: July 19, 2019
Last Updated: 09/26/2026